Boston Scientific BSX Asia-Pacific — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Boston Scientific's asia-pacific — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Boston Scientific's asia-pacific — net sales?
- Boston Scientific (BSX) reported asia-pacific — net sales of $803M in Q1 2026.
- How has Boston Scientific's asia-pacific — net sales changed year-over-year?
- Boston Scientific's asia-pacific — net sales increased by 14.6% year-over-year, from $701M to $803M.
- What is the long-term trend for Boston Scientific's asia-pacific — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's asia-pacific — net sales has grown at a 10.5% compound annual growth rate (CAGR), from $2.07B to $3.08B.
- What does asia-pacific — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and related services within the Asia-Pacific geographic region. It reflects the company's market penetration, adoption of minimally invasive technologies, and commercial success in these specific international healthcare markets. Tracking this figure helps assess the company's growth trajectory and competitive positioning in high-potential, emerging, and established Asian healthcare economies.